Highlander Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $36.5K | Hold |
852
| – | – | 0.01% | 443 |
|
|
2023
Q4 | $31.6K | Hold |
852
| – | – | 0.01% | 465 |
|
|
2023
Q3 | $31K | Buy |
852
+640
| +302% | +$22.7K | 0.01% | 438 |
|
|
2023
Q2 | $8K | Hold |
212
| – | – | ﹤0.01% | 556 |
|
|
2023
Q1 | $8K | Hold |
212
| – | – | ﹤0.01% | 539 |
|
|
2022
Q4 | $7K | Hold |
212
| – | – | ﹤0.01% | 523 |
|
|
2022
Q3 | $6K | Sell |
212
-1
| -0.5% | -$38 | ﹤0.01% | 514 |
|
|
2022
Q2 | $12K | Hold |
213
| – | – | 0.01% | 453 |
|
|
2022
Q1 | $12K | Hold |
213
| – | – | 0.01% | 456 |
|
|
2021
Q4 | $12K | Hold |
213
| – | – | 0.01% | 451 |
|
|
2021
Q3 | $10K | Hold |
213
| – | – | 0.01% | 460 |
|
|
2021
Q2 | $11K | Hold |
213
| – | – | 0.01% | 466 |
|
|
2021
Q1 | $9K | Hold |
213
| – | – | ﹤0.01% | 501 |
|
|
2020
Q4 | $10K | Hold |
213
| – | – | 0.01% | 481 |
|
|
2020
Q3 | $10K | Hold |
213
| – | – | 0.01% | 477 |
|
|
2020
Q2 | $11K | Hold |
213
| – | – | 0.01% | 467 |
|
|
2020
Q1 | $10K | Hold |
213
| – | – | 0.01% | 476 |
|
|
2019
Q4 | $12K | Hold |
213
| – | – | 0.01% | 490 |
|
|
2019
Q3 | $11K | Hold |
213
| – | – | 0.01% | 509 |
|
|
2019
Q2 | $11K | Sell |
213
-213
| -50% | -$10.7K | 0.01% | 537 |
|
|
2019
Q1 | $22K | Hold |
426
| – | – | 0.01% | 440 |
|
|
2018
Q4 | $20K | Hold |
426
| – | – | 0.01% | 444 |
|
|
2018
Q3 | $21K | Hold |
426
| – | – | 0.01% | 486 |
|
|
2018
Q2 | $21K | Hold |
426
| – | – | 0.01% | 491 |
|
|
2018
Q1 | $21K | Hold |
426
| – | – | 0.01% | 483 |
|
|
2017
Q4 | $19K | Hold |
426
| – | – | 0.01% | 504 |
|
|
2017
Q3 | $22K | Hold |
426
| – | – | 0.02% | 484 |
|
|
2017
Q2 | $23K | Hold |
426
| – | – | 0.02% | 486 |
|
|
2017
Q1 | $22K | Hold |
426
| – | – | 0.02% | 490 |
|
|
2016
Q4 | $20K | Hold |
426
| – | – | 0.02% | 510 |
|
|
2016
Q3 | $23K | Hold |
426
| – | – | 0.02% | 499 |
|
|
2016
Q2 | $23K | Hold |
426
| – | – | 0.02% | 500 |
|
|
2016
Q1 | $22K | Hold |
426
| – | – | 0.02% | 499 |
|
|
2015
Q4 | $21K | Hold |
426
| – | – | 0.02% | 517 |
|
|
2015
Q3 | $20K | Hold |
426
| – | – | 0.02% | 534 |
|
|
2015
Q2 | $22K | Hold |
426
| – | – | 0.02% | 516 |
|
|
2015
Q1 | $25K | Hold |
426
| – | – | 0.02% | 514 |
|
|
2014
Q4 | $23K | Buy |
+426
| New | +$23.8K | 0.02% | 538 |
|
|
2014
Q2 | – | Sell |
-140
| Closed | -$9.35K | – | 831 |
|
|
2014
Q1 | $9.35K | Hold |
140
| – | – | 0.01% | 677 |
|
|
2013
Q4 | $9.34K | Hold |
140
| – | – | 0.01% | 679 |
|
|
2013
Q3 | $8.78K | Sell |
140
-80
| -36% | -$5.15K | 0.01% | 684 |
|
|
2013
Q2 | $13.7K | Buy |
+220
| New | +$14K | 0.01% | 581 |
|
Other funds holding GSK
JEST
Highlander Capital Management's GSK Position: Q1 2024 in Review
Highlander Capital Management held its GSK (GSK) position steady in Q1 2024 at 852 shares worth $36.5K. The position accounts for 0.01% of the portfolio, ranked #443.
Highlander Capital Management first reported a position in GSK in Q2 2013 and has held it in 42 quarters since. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.
- Highlander Capital Management held 852 shares of GSK worth $36.5K as of Q1 2024.
- Highlander Capital Management left its GSK share count unchanged in Q1 2024.
- GSK made up 0.01% of Highlander Capital Management's portfolio in Q1 2024, its #443 holding.
- Highlander Capital Management first reported a position in GSK in Q2 2013 and has held it in 42 quarters since.
- 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.